Neuropeptide FF Antikörper (PE)
Kurzübersicht für Neuropeptide FF Antikörper (PE) (ABIN2177994)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NPFF/FMRFamide
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Kommentare
-
Exitation/Emission: 480,565nm/578nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for 12 months.
-
-
- Neuropeptide FF (NPFF)
-
Andere Bezeichnung
- Npff
-
Hintergrund
-
FMRFamide related peptides are morphine modulating peptides that have many physiologic effects, including the modulation of morphine induced analgesia, elevation of arterial blood pressure, and increased somatostatin secretion from the pancreas. Neuropeptide FF potentiates and sensitizes ACCN2 and ACCN3 channels.
Synonyms: FMFRamide related peptide precursor, FMRFAL, FMRFamide related peptides precursor, FMRFamide-related peptides [Precursor], Neuropeptide FF amide peptide precursor, NPFF, NPFF protein, NPFF_HUMAN. -
Gen-ID
- 8620
Target
-